A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
Clinical trial NCT07024823 · RECRUITING
Trial details
- NCT number
- NCT07024823
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-09
- Primary completion
- 2026-12-25
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.